Posterior capsular opacification (PCO) is common after cataract surgery. Recurrence is very rare after a successful Yttrium aluminium-garnet (YAG) capsulotomy in adults. We report a case of visual axis re-opacification after a successful YAG capsulotomy for PCO in an adult. A 60-year male underwent phacoemulsification with +20.0 D acrylic hydrophobic intraocular lens implantation and silicon oil removal (SOR) five months after a successful retinal detachment repair. He underwent a capsulotomy after two months of surgery; however, the visual axis re-opacified after three more months. A YAG anterior hyaloidotomy resulted into improved vision which was maintained over further follow-up. In a post-vitrectomy pseudophakic eye, compression by silicon oil on the posterior capsule is lost after SOR, causing easier and faster migration of lens epithelial cells from the equator to the centre forming an early PCO. Recurrence is possible due to the proliferation of lens epithelial cells along anterior hyaloid also. This case highlights the infrequent scenario of visual axis re-opacification and therefore has teaching value for residents and trainee doctors, who should be made aware of this occurrence. Patients should be explained about this possibility when undergoing YAG capsulotomy in complicated cases such as this one.
Introduction
Visual axis opacification after cataract surgery can be a disturbing experience for the patient. Posterior capsular opacification and anterior hyaloid face (AHF) opacification are the possible causes, with the former being the cause in a predominant majority. 1,2 AHF opacification occurs more commonly after paediatric cataract surgery, thus necessitating an anterior vitrectomy along with posterior capsulorhexis as a preventive measure. However, it is rarely seen in adults.
The treatment for both these causes of visual axis opacification is Nd:YAG laser assisted disruption of the opacified capsule/membrane done as an outpatient procedure. The procedure is fairly quick, causing a rapid recovery of vision if there are no other co-morbid factors. Mostly, this is an one-time procedure.
We report a case of visual axis re-opacification after a successful YAG capsulotomy for posterior capsular opacification in an adult. This case represents an important clinical lesson that visual axis re-opacification can occur rarely in adults and should be kept in mind as a possibility.
Case report
A 60-year-old man presented to us with sudden onset blurring of vision in the left eye due to a rhegmatogenous retinal detachment. His presenting corrected distance visual acuity (CDVA) was 20/400. He underwent an uneventful pars plana vitrectomy with silicone oil tamponade and 360-degree scleral buckle placement. He developed a nongranulomatous anterior uveitis in the immediate postoperative period which responded to topical steroids and resolved leaving patchy posterior synaechiae as the sequelae. The postoperative course was uneventful up to the fifth month follow-up when he developed a posterior subcapsular cataract ( Fig. 1A) . He underwent phacoemulsification, synaechiolysis and silicon oil removal in the left eye. A +20.0 D hydrophobic acrylic lens (Acrysof IQ, Alcon, CA) was implanted. The postoperative corrected distance visual acuity (CDVA) was 20/40 at 1 week postoperatively. However, over the next two months of follow-up, we found that there was a deterioration of CDVA (20/120). He was found to have a dense posterior capsular opacity (Fig. 1B) .
The retina was well attached. An Nd-YAG capsulotomy was performed. Six shots of 0.5 mJ power were used in single pulse fashion circumferentially to create the opening. The capsulotomy was complete as evidenced in the photograph (Fig. 1C ). The CDVA again improved to 20/40.
The patient was on regular follow-up. Three months after the YAG capsulotomy, he complained of blurring of vision again. The CDVA was 20/80. On slit lamp evaluation a new visual axis opacification was seen (Figs. 1D and 2). The margins of the old capsulotomy were at the same location; hence, it was not a spontaneous closure, as has been reported before. 2, 3 Lens epithelial cell proliferation was seen over the intact anterior hyaloid phase.
The retina was attached and the macula was normal. A pseudophakic eye with an intact posterior capsule and anterior hyaloid phase can be considered as a double set of membranes with each having a potential for opacification. So the differential diagnosis in this case was spontaneous closure of the posterior capsulotomy or AHF opacification as the possible causes of re-opacification of the visual axis and decrease in CDVA. As the capsulotomy margins were intact, this was not a case of spontaneous closure. Furthermore, anterior hyaloid face was seen clearly due to the migrated epithelial cells using it as a scaffold (Fig. 2) .
After a thorough retinal evaluation, a YAG anterior hyaloidotomy was performed. Five shots of 0.3 mJ at single pulse were applied in a circular fashion. The visual axis was successfully cleared (Fig. 1E) . The CDVA improved to 20/40 and was maintained till the last follow-up 6 months after capsulotomy ( Fig. 1F ).
Discussion
Recurrence of visual axis re-opacification in an adult after an adequately large YAG Capsulotomy is a rare phenomenon. 4 It has also been reported rarely in cases of myotonic dystrophy. 3 There were no signs of the disease in our patient.
Our case was interesting because there was a clear documentation against spontaneous closure of the capsulotomy as can be seen from the slit lamp photograph. Another interesting occurrence in our case was the 'early' (within two months of silicon oil removal) PCO formation. We reviewed literature and evaluated possible reasons for both the early PCO and spontaneous visual axis reopacification in our case.
A recent study has shown that PCO progresses more rapidly in patients undergoing combined or sequential cataract surgery and PPV than in patients undergoing cataract surgery alone. 5 Elevated cytokines caused by postoperative inflammation have been suggested to cause LEC proliferation via autocrine and/or paracrine signalling. [5] [6] [7] The second and the more complicated question in our case was the potential cause and origin of the visual axis re-opacification after the capsulotomy. Groot et al. have demonstrated that even after a posterior capsulorhexis, lens epithelial cells (LECs) have the potential to proliferate beyond the margins of the capsulorhexis. LECs can also grow on the anterior hyaloid membrane. 8 In phakic vitrectomy, to avoid a lens touch, a thin sheet of anterior vitreous may be left untouched immediately posterior to the lens. This may serve as a scaffold for the lens epithelial cells to migrate from the equatorial region to the centre even after a YAG posterior capsulotomy.
We hypothesise that YAG capsulotomy removed PCO from the central part. Recurrence of visual axis opacification may have occurred due to progression by proliferation of lens epithelial cells along the anterior hyaloid phase.
Ozyol et al. noted that occurrence of retinal complications after inadvertent anterior hyaloid disruption during posterior capsulotomy is 12.7 times higher than when only the posterior capsule is disrupted, adjusted for total energy used. 9 As the vitreous gel is liquefied and there are higher chances of PVD with age, this risk seems to be higher in adult cases compared to paediatric eyes. Therefore anterior hyaloidotomy should be reserved only for cases such as above and should not be routinely performed during YAG capsulotomy.
There are important lessons to be learnt from this case. Extra care should be taken during cortex wash in post vitrec-tomised eyes to avoid residual lens matter. In a post vitrectomy and sequential cataract surgery pseudophakic eye, there can be recurrence of visual axis opacification due to proliferation of lens epithelial cells along the anterior hyaloid even after a successful YAG capsulotomy. Possibility of recurrence should be explained to the patient in such cases. This entity may also be termed an 'after after-cataract', an extension of 'after-cataract', the colloquial term for PCO.
